Author

Xue Yang

Monash UniversityORCID 0000-0002-1016-5584Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Xue Yang3 papers · University of California, Merced

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

Anderly C. ChüehiD· 1 shared Andrew M. EllisdoniD· 1 shared Bao V. NguyeniD· 1 shared Changyuan HuiD· 1 shared Charles Bayly-JonesiD· 1 shared David R. CroucheriD· 1 shared Elizabeth V. NguyeniD· 1 shared Kimberley C. ClarkiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Anderly C. ChüehORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologyNature CommunicationsPeer-reviewedFeb 21, 2025

Feed-forward stimulation of CAMK2 by the oncogenic pseudokinase PEAK1 generates a therapeutically "actionable" signalling axis in triple negative breast cancer

Xue Yang, Xiuquan Ma, Tianyue Zhao…·Roger J. Daly

This study identifies a novel feed-forward signalling axis between PEAK1 and CAMK2 in TNBC, showing that targeting CAMK2 can inhibit PEAK1-driven oncogenic processes.

10 citations

humanproteomics

𝕏 PostBluesky